| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2018-08-07 | TG-1101 (ublituximab) | multiple sclerosis | 3 | TG Therapeutics (USA - NY) | Autoimmune diseases - Neurodegenerative diseases |
| 2018-08-06 | biomarker blood tumor mutational burden (bTMB) | Foundation Medicine (USA - MA) Roche (Switzerland) | Cancer - Oncology | ||
| 2018-08-02 | remetinostat | basal cell carcinoma | 2 | Medivir (Sweden) | Cancer - Oncology |
| 2018-08-01 | ADVM-053 | hereditary angioedema (HAE) | preclinical | Adverum Biotechnologies (USA - CA) | Rare diseases - Genetic diseases - Hematological diseases |
| 2018-08-01 | ADVM-043 | alpha-1 antitrypsin (A1AT) deficiency | 1-2 | Adverum Biotechnologies (USA - CA) | Rare diseases - Genetic diseases |
| 2018-07-27 | MIV-711 | knee osteoarthritis | 2 | Medivir (Sweden) | Rheumatic diseases - Inflammatory diseases – Bone diseases |
| 2018-07-26 | DTX401 | glycogen storage disease type Ia (GSDIa) | 1-2 | Ultragenyx Pharmaceutical (USA - CA) | Rare diseases - Genetic diseases - Metabolic diseases |
| 2018-07-25 | anti-Abeta antibody MABT5102A (crenezumab) | mild to moderate Alzheimer's disease | 2 | AC Immune (Switzerland) Genentech, a member of Roche Group (USA - Switzerland) | Neurodegenerative diseases |
| 2018-07-24 | CYAD-101 | unresectable colorectal cancer | 1 | Celyad (Belgium) | Cancer - Oncology |
| 2018-07-24 | doravirine (MK-1439) | HIV-1 infection | 3 | Merck&Co (USA - NJ) | Infectious diseases |
| 2018-07-24 | dolutegravir and lamivudine | HIV-1 infection in adults | 3 | ViiV Healthcare (UK - USA) | Infectious diseases |
| 2018-07-24 | pamiparib (BGB-290) | advanced gastric cancer | 3 | BeiGene (China) | Cancer - Oncology |
| 2018-07-23 | SB-318 (adeno-associated virus serotype 2/6 (rAAV2/6) vectors encoding zinc finger nucleases (ZFNs) and the human alpha-L-iduronidase (hIDUA) gene) | mucopolysaccharidosis I (Hurler syndrome) | 1-2 | Sangamo Therapeutics (USA - CA) | Rare diseases - Genetic diseases |
| 2018-07-22 | tislelizumab (BGB-A317) | relapsed or refractory Hodgkin lymphoma | 2 | BeiGene (China) | Cancer - Oncology |
| 2018-07-19 | ATOR-1015 | 1 | Alligator Bioscience (Sweden) | Cancer - Oncology | |
| 2018-07-17 | crenezumab | Alzheimer's disease | 3 | Roche (Switzerland) | Neurodegenerative diseases |
| 2018-07-08 | ART-I02 | rheumatoid arthritis, osteoarthritis | 1b | Arthrogen (The Netherlands) | Autoimmune diseases – Inflammatory diseases - Rheumatic diseases |
| 2018-07-04 | Cabometyx™ (cabozantinib) | 3 | Exelixis (USA - CA) Ipsen (France) | ||
| 2018-07-04 | Cabometyx™ (cabozantinib) | 3 | Exelixis (USA - CA) Ipsen (France) | ||
| 2018-06-29 | prurisol | moderate-to-severe plaque psoriasis | 2b | Innovation Pharmaceuticals (USA - MA) | Autoimmune diseases - Dermatological diseases |
